This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. IRIS investigators: imatinib compared with interferon low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994–1004.
Hehlmann R . Current CML therapy: progress and dilemma. Leukemia 2003; 17: 1010–1012.
Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C et al. International STI571 CML Study Group: hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645–652.
Bergeron A, Bergot E, Vilela G, Ades L, Devergie A, Esperou H et al. Hypersensitivity pneumonitis related to imatinib mesylate. J Clin Oncol 2002; 20: 4271–4272.
Rosado MF, Donna E, Ahn YS . Challenging problems in advanced malignancy: case 3. Imatinib mesylate-induced interstitial pneumonitis. J Clin Oncol 2003; 21: 3171–3173.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yokoyama, T., Miyazawa, K., Kurakawa, E. et al. Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration. Leukemia 18, 645–646 (2004). https://doi.org/10.1038/sj.leu.2403251
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403251
This article is cited by
-
Repurposing of Kinase Inhibitors for Treatment of COVID-19
Pharmaceutical Research (2020)
-
CT and MRI findings in focal eosinophilic infiltration of the liver
Abdominal Radiology (2017)
-
Nilotinib-induced interstitial lung disease
International Journal of Hematology (2013)
-
A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11Â months
International Journal of Hematology (2010)